Aurora Cannabis ROE 2017-2019 | ACB

Current and historical return on equity (ROE) values for Aurora Cannabis (ACB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Aurora Cannabis ROE for the three months ending June 30, 2019 was -0.83%.
Aurora Cannabis ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $-0.22B $3.32B -6.62%
2019-03-31 $-0.16B $3.31B -5.56%
2018-12-31 $-0.05B $3.25B -2.28%
2018-09-30 $0.14B $3.37B 8.80%
2018-06-30 $0.06B $1.23B 7.70%
2018-03-31 $-0.01B $1.10B -2.11%
2017-12-31 $0.01B $0.44B 2.51%
2017-09-30 $-0.00B $0.20B -3.33%
2017-06-30 $-0.01B $0.17B -24.24%
2017-03-31 $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.724B $0.215B
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.126B 27.02
Medtronic (MDT) Ireland $144.847B 20.33
Stryker (SYK) United States $74.230B 24.96
Boston Scientific (BSX) United States $55.990B 26.43
Baxter (BAX) United States $40.262B 24.42
EssilorLuxottica Societe Anonyme (ESLOY) France $32.646B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.479B 18.49
Terumo (TRUMY) Japan $26.826B 33.48
Lonza Group Ag (LZAGY) Switzerland $25.848B 0.00
Coloplast (CLPBY) Denmark $24.710B 39.45
ResMed (RMD) United States $20.688B 38.16
Smith & Nephew SNATS (SNN) United Kingdom $18.505B 0.00
Sunny Optical Technology (SNPTF) China $18.021B 0.00
Insulet (PODD) United States $10.756B 511.73
Bio-Rad Laboratories (BIO) United States $10.475B 50.28
Canopy Growth (CGC) Canada $7.071B 0.00
Hill-Rom Holdings (HRC) United States $6.970B 20.53
Perrigo (PRGO) Ireland $6.683B 12.46
William Demant Holdings (WILYY) Denmark $6.665B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.015B 40.64
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.751B 29.54
GW Pharmaceuticals (GWPH) United Kingdom $3.498B 0.00
ICU Medical (ICUI) United States $3.474B 22.66
Neogen (NEOG) United States $3.331B 55.74
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.989B 0.00
Quidel (QDEL) United States $2.472B 23.46
National Vision Holdings (EYE) United States $2.103B 47.83
Agios Pharmaceuticals (AGIO) United States $1.910B 0.00
Cardiovascular Systems (CSII) United States $1.587B 0.00
InMode (INMD) Israel $1.452B 0.00
VAREX IMAGING (VREX) United States $1.251B 28.84
Aphria (APHA) $1.250B 0.00
AtriCure (ATRC) United States $1.103B 0.00
Phibro Animal Health (PAHC) United States $0.926B 17.34
Lantheus Holdings (LNTH) United States $0.845B 21.11
Eagle Pharmaceuticals (EGRX) United States $0.845B 21.54
NanoString Technologies (NSTG) United States $0.829B 0.00
TG Therapeutics (TGTX) United States $0.739B 0.00
Omeros (OMER) United States $0.677B 0.00
LeMaitre Vascular (LMAT) United States $0.660B 37.35
PetIQ (PETQ) United States $0.641B 15.68
Cerus (CERS) United States $0.574B 0.00
Quanterix (QTRX) United States $0.563B 0.00
HEXO (HEXO) $0.545B 0.00
Organigram Holdings (OGI) Canada $0.529B 0.00
Surmodics (SRDX) United States $0.527B 55.04
OraSure Technologies (OSUR) United States $0.511B 30.67
Owens & Minor (OMI) United States $0.429B 15.88
MacroGenics (MGNX) United States $0.389B 0.00
Utah Medical Products (UTMD) United States $0.381B 27.58
BioLife Solutions (BLFS) United States $0.340B 104.56
Meridian Bioscience (VIVO) United States $0.340B 11.69
Zynex (ZYXI) United States $0.295B 33.33
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.274B 0.00
Viemed Healthcare (VMD) United States $0.261B 0.00
Bovie Medical (APYX) United States $0.245B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Repro-Med Systems (KRMD) United States $0.183B 0.00
Vapotherm (VAPO) United States $0.169B 0.00
InfuSystems Holdings (INFU) United States $0.143B 0.00
Cytosorbents (CTSO) United States $0.143B 0.00
Fonar (FONR) United States $0.134B 9.40
Female Health (VERU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chimerix (CMRX) United States $0.103B 0.00
United-Guardian (UG) United States $0.089B 22.43
Chembio Diagnostics (CEMI) United States $0.079B 0.00
Nephros (NEPH) United States $0.068B 0.00
MRI Interventions (MRIC) United States $0.055B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
MTech Acquisition (KERN) United States $0.045B 0.00
Surface Oncology (SURF) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Senestech (SNES) United States $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Myomo (MYO) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00